Avalo Therapeutics, Inc. · NASDAQ:AVTX
Chan Mitchell sold 3,167 Avalo Therapeutics, Inc. shares (Form 4)
Traded May 6, 2026 · Filed May 7, 2026
On May 6, 2026, Chan Mitchell (Director) sold 3,167 Avalo Therapeutics, Inc. shares at US$22.88 for US$72,461 under a trading plan, leaving 3,166 shares. Filed May 7, 2026 (Form 4).
- Sold
- 3,167 shares
- Price
- US$22.88
- Value
- US$72,461
- Holding after
- 3,166 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- Director
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| May 6, 2026 | Common Stock | Sale | 3,167 | US$22.88 | 3,166 | Direct |